Cargando…
Ruxolitinib inhibits poly(I:C) and type 2 cytokines‐induced CCL5 production in bronchial epithelial cells: A potential therapeutic agent for severe eosinophilic asthma
RATIONALE: Severe eosinophilic asthma is characterized by airway eosinophilia and corticosteroid‐resistance, commonly overlapping with type 2 inflammation. It has been reported that chemokine (C‐C motif) ligand 5 (CCL5) is involved in the exacerbation of asthma by RNA virus infections. Indeed, treat...
Autores principales: | Sada, Mitsuru, Watanabe, Masato, Inui, Toshiya, Nakamoto, Keitaro, Hirata, Aya, Nakamura, Masuo, Honda, Kojiro, Saraya, Takeshi, Kurai, Daisuke, Kimura, Hirokazu, Ishii, Haruyuki, Takizawa, Hajime |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127547/ https://www.ncbi.nlm.nih.gov/pubmed/33534941 http://dx.doi.org/10.1002/iid3.397 |
Ejemplares similares
-
Serum sST2 levels predict severe exacerbation of asthma
por: Watanabe, Masato, et al.
Publicado: (2018) -
Soluble ST2 enhances IL‐33–induced neutrophilic and pro‐type 2 inflammation in the lungs
por: Watanabe, Masato, et al.
Publicado: (2022) -
Detailed Analyses of Molecular Interactions between Favipiravir and RNA Viruses In Silico
por: Shirai, Tatsuya, et al.
Publicado: (2022) -
Serum Reactive Oxygen Metabolite Levels Predict Severe Exacerbations of Asthma
por: Nakamoto, Keitaro, et al.
Publicado: (2016) -
The molecular epidemiology of respiratory viruses associated with asthma attacks: A single-center observational study in Japan
por: Saraya, Takeshi, et al.
Publicado: (2017)